相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Angiotensin AT2 Receptor: Froma Binding Site to a Novel Therapeutic Target
U. Muscha Steckelings et al.
PHARMACOLOGICAL REVIEWS (2022)
Idiopathic pulmonary fibrosis and pulmonary hypertension: Heracles meets the Hydra
Keshava Rajagopal et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease
Aaron Waxman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Long-Term Outcomes in Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension in the Modern Treatment Era: Meta-Analyses of Randomized, Controlled Trials and Observational Registries
Dinesh Khanna et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Combining Data Sets as Well as Therapies Shows Improved Outcome in Connective Tissue Disease-Associated Pulmonary Hypertension
Christopher P. Denton et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Automated Digital Quantification of Pulmonary Fibrosis in Human Histopathology Specimens
Lauren C. Testa et al.
FRONTIERS IN MEDICINE (2021)
Seven days treatment with the angiotensin II type 2 receptor agonist C21 in hospitalized COVID-19 patients; a placebo-controlled randomised multi-centre double-blind phase 2 trial
Goran Tornling et al.
ECLINICALMEDICINE (2021)
The pan-PPAR agonist lanifibranor reduces development of lung fibrosis and attenuates cardiorespiratory manifestations in a transgenic mouse model of systemic sclerosis
Emma Derrett-Smith et al.
ARTHRITIS RESEARCH & THERAPY (2021)
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study
Jelena Blagojevic et al.
CLINICAL RHEUMATOLOGY (2020)
Pulmonary vasculopathy in explanted lungs from patients with interstitial lung disease undergoing lung transplantation
Yaniv Dotan et al.
BMJ OPEN RESPIRATORY RESEARCH (2020)
The Clinical Efficacy of Pulmonary Hypertension-Specific Agents in Idiopathic Pulmonary Fibrosis: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Jonghoo Lee et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2020)
The new haemodynamic definition of pulmonary hypertension: evidence prevails, finally!
Marius M. Hoeper et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives
Marc Humbert et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling
Anandharajan Rathinasabapathy et al.
FRONTIERS IN PHYSIOLOGY (2018)
The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury
Anandharajan Rathinasabapathy et al.
FRONTIERS IN PHYSIOLOGY (2018)
Quantification of Pulmonary Fibrosis in a Bleomycin Mouse Model Using Automated Histological Image Analysis
Jean-Claude Gilhodes et al.
PLOS ONE (2017)
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2016)
A global view of pulmonary hypertension
Marius M. Hoeper et al.
LANCET RESPIRATORY MEDICINE (2016)
Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study
Veronika K. Jaeger et al.
PLOS ONE (2016)
Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis
E. Bruce et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Angiotensin type 2 receptors: blood pressure regulation and end organ damage
Colin Sumners et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
AT2 Receptor Activities and Pathophysiological Implications
Luis C. Matavelli et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2015)
Dose-dependent, therapeutic potential of angiotensin-(1-7) for the treatment of pulmonary arterial hypertension
Siegfried Breitling et al.
PULMONARY CIRCULATION (2015)
Oral Delivery of Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Bioencapsulated in Plant Cells Attenuates Pulmonary Hypertension
Vinayak Shenoy et al.
HYPERTENSION (2014)
The role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series)
Bradley A. Maron et al.
PULMONARY CIRCULATION (2014)
Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury
Gerry T. M. Wagenaar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2013)
Endothelial Injury in a Transforming Growth Factor β-Dependent Mouse Model of Scleroderma Induces Pulmonary Arterial Hypertension
Emma C. Derrett-Smith et al.
ARTHRITIS AND RHEUMATISM (2013)
Dysregulated Renin-Angiotensin-Aldosterone System Contributes to Pulmonary Arterial Hypertension
Frances S. de Man et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Pulmonary Hypertension and Idiopathic Pulmonary Fibrosis A Tale of Angiogenesis, Apoptosis, and Growth Factors
Laszlo Farkas et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2011)
Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors
Sanja Bosnyak et al.
CLINICAL SCIENCE (2011)
Evidence for Angiotensin-converting Enzyme 2 as a Therapeutic Target for the Prevention of Pulmonary Hypertension
Anderson J. Ferreira et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Pathology of pulmonary hypertension
Rubin M. Tuder et al.
CLINICS IN CHEST MEDICINE (2007)
Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas
RAS Santos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
分享论文
